ANRO (STOCKS)
Alto Neuroscience Inc.
$26.200000
+3.420000 (+15.01%)
Prev close: $22.780000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Amit Etkin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $823.43M
- Employees
- 76
- P/E (TTM)
- -10.15
- P/B (TTM)
- 4.81
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $4.05M |
| Operating Expenses | $66.31M |
| Research and Development | $44.42M |
| Other Operating Expenses | $21.88M |
| Operating Income/Loss | -$66.31M |
| Income/Loss From Continuing Operations After Tax | -$62.26M |
| Income/Loss From Continuing Operations Before Tax | -$62.26M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$62.26M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$62.26M |
| Net Income/Loss Available To Common Stockholders, Basic | -$62.26M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.30 |
| Diluted Earnings Per Share | -$2.30 |
| Basic Average Shares | 27,799,000 |
| Diluted Average Shares | 27,799,000 |
| Assets | $147.01M |
| Current Assets | $139.45M |
| Prepaid Expenses | $879.00K |
| Other Current Assets | $138.57M |
| Noncurrent Assets | $7.56M |
| Fixed Assets | $2.03M |
| Other Non-current Assets | $5.53M |
| Liabilities | $35.45M |
| Current Liabilities | $9.05M |
| Accounts Payable | $2.06M |
| Wages | $3.21M |
| Other Current Liabilities | $3.78M |
| Noncurrent Liabilities | $26.40M |
| Equity | $111.56M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $111.56M |
| Temporary Equity | $0.00 |
| Temporary Equity Attributable To Parent | $0.00 |
| Liabilities And Equity | $147.01M |
| Net Cash Flow From Operating Activities | -$53.27M |
| Net Cash Flow From Operating Activities, Continuing | -$53.27M |
| Net Cash Flow From Investing Activities | -$530.00K |
| Net Cash Flow From Investing Activities, Continuing | -$530.00K |
| Net Cash Flow From Financing Activities | $9.94M |
| Net Cash Flow From Financing Activities, Continuing | $9.94M |
| Exchange Gains/Losses | -$23.00K |
| Net Cash Flow | -$43.89M |
| Net Cash Flow, Continuing | -$43.86M |
| Other Comprehensive Income/Loss | -$44.46M |
| Other Comprehensive Income/Loss Attributable To Parent | $109.00K |